Trial site
Clinical Research Institute
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Migraine10 trials
- Alzheimer disease1 trial
- Epilepsy1 trial
- Obesity1 trial
- Phase
- Phase 35 trials
- Phase 45 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Completed4 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Pfizer6 trials
- Eli Lilly and Company2 trials
- TriGemX Bio, Inc.2 trials
- Biohaven Therapeutics Ltd.1 trial
- Mayo Clinic1 trial
- and 1 more
Running trials
Recruiting
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Recruiting
Recruiting
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
Completed
Completed
Completed
Terminated
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
Site data: ClinicalTrials.govUpdated 14 Nov 2026